Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

RIP3 expression induces a death profile change in U2OS osteosarcoma cells after 5-ALA-PDT.

Coupienne I, Fettweis G, Piette J.

Lasers Surg Med. 2011 Sep;43(7):557-64. doi: 10.1002/lsm.21088.

PMID:
22057483
2.

The serine threonine kinase RIP3: lost and found.

Morgan MJ, Kim YS.

BMB Rep. 2015 Jun;48(6):303-12. Review.

3.

Molecular effectors of multiple cell death pathways initiated by photodynamic therapy.

Buytaert E, Dewaele M, Agostinis P.

Biochim Biophys Acta. 2007 Sep;1776(1):86-107. Review.

PMID:
17693025
4.

Assessing autophagy in the context of photodynamic therapy.

Reiners JJ Jr, Agostinis P, Berg K, Oleinick NL, Kessel D.

Autophagy. 2010 Jan;6(1):7-18. Review.

5.

Necroptosis, necrostatins and tissue injury.

Smith CC, Yellon DM.

J Cell Mol Med. 2011 Sep;15(9):1797-806. doi: 10.1111/j.1582-4934.2011.01341.x. Review.

6.

Autophagic death probed by photodynamic therapy.

Kessel D.

Autophagy. 2015;11(10):1941-3. doi: 10.1080/15548627.2015.1078960. Review.

7.

Recent insights into cell death and autophagy.

Fitzwalter BE, Thorburn A.

FEBS J. 2015 Nov;282(22):4279-88. doi: 10.1111/febs.13515. Review.

8.

Killing a cancer: what are the alternatives?

Kreuzaler P, Watson CJ.

Nat Rev Cancer. 2012 May 11;12(6):411-24. doi: 10.1038/nrc3264. Review.

PMID:
22576162
9.

Cell apoptosis, autophagy and necroptosis in osteosarcoma treatment.

Li J, Yang Z, Li Y, Xia J, Li D, Li H, Ren M, Liao Y, Yu S, Chen Y, Yang Y, Zhang Y.

Oncotarget. 2016 Jul 12;7(28):44763-44778. doi: 10.18632/oncotarget.8206. Review.

Supplemental Content

Support Center